Evaluation of Efficacy of Trifluridine/Tipiracil Plus an Anti-IL-1α True Human Antibody Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine
Clinical trial NCT05201352 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05201352
- Sponsor
- Centre Georges Francois Leclerc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-13
- Primary completion
- 2026-10-13
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.